
    
      An international, multi-centre, prospective, open-label, randomised, 2-arm, cross-over study
      with 14-days once daily treatment in subjects with psoriasis vulgaris. To gather insight on
      how product attributes affect usability by investigating the factors that are thought to
      influence patient preference to topical anti-psoriatic treatments.
    
  